BIODEL INC. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • April 15th, 2015 • Biodel Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 15th, 2015 Company Industry JurisdictionBiodel Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of 32,608,696 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 4,891,304 additional shares (the “Optional Securities”) of common stock, par value $0.01 per share (“Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
BIODEL INC. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • April 2nd, 2015 • Biodel Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 2nd, 2015 Company Industry JurisdictionBiodel Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of [ ] shares (the “Firm Securities”) and, at the election of the Underwriters, up to [ ] additional shares (the “Optional Securities”) of common stock, par value $0.01 per share (“Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
BIODEL INC. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • June 20th, 2013 • Biodel Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 20th, 2013 Company Industry JurisdictionBiodel Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of 4,482,760 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 672,414 additional shares (the “Optional Securities”) of common stock, par value $0.01 per share (“Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
Brookdale Senior Living Inc. Underwriting AgreementUnderwriting Agreement • June 14th, 2011 • Brookdale Senior Living Inc. • Services-nursing & personal care facilities • New York
Contract Type FiledJune 14th, 2011 Company Industry JurisdictionBrookdale Senior Living Inc., a Delaware corporation (the “Company”), proposes, upon the terms and subject to the conditions set forth herein, to issue and sell to the underwriters listed on Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”), $275 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2018 (the “Initial Securities”) and, at the option of the Underwriters, up to an additional $41.25 million principal amount of its 2.75% Convertible Senior Notes due 2018 (the “Option Securities” and, together with the Initial Securities, the “Securities”) to cover over-allotments, if any. The Securities will be convertible into shares of common stock (the “Underlying Securities”) of the Company, par value $0.01 per share (the “Common Stock”). The Securities will be issued pursuant to an indenture, together with any officers’ certificate or supplement thereto establishing the terms of the Securities, each to be d